GAVISCON LIQUID

Posology Adults and children 12 years and over:

One to two sachets after meals and at bedtime (up to four times a day).

Children under 12 years:

Should be given only on medical advice.

Duration of treatment:

If symptoms do not improve after seven days, the clinical situation should be reviewed.

Special Patient groups Elderly:

No dose modifications necessary for this age group.

Hepatic impairment:

No modifications necessary. 4). Method of administration For oral administration

Adverse reactions have been ranked under headings of frequency using the following convention: Very rare: <1/10,000 System Organ Class Frequency Adverse Event Immune System Disorders Very rare Anaphylactic and anaphylactoid reactions.

Hypersensitivity reactions such as urticaria Respiratory, Thoracic and Mediastinal Disorders Very rare Respiratory effects such as broncospasm. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorization of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

If symptoms do not improve after seven days, the clinical situation should be reviewed. 62% of the WHO recommended maximum daily intake for sodium. 04% of the WHO recommended maximum daily intake for sodium. This product is considered high in sodium.

g. in some cases of congestive heart failure and renal impairment). 6 mmol) of calcium carbonate. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed).

2

4).